BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2475431)

  • 21. In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis.
    Myers KJ; Dougherty JP; Ron Y
    J Immunol; 1993 Aug; 151(4):2252-60. PubMed ID: 7688395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-inflammatory expression of fibronectin (Fn) and Ia in acute experimental allergic encephalomyelitis (EAE): modulation of endothelial cells (EC) in the immune response detected by quantitative immunoperoxidase studies using monoclonal antibodies (MAb).
    Sobel RA; Blanchette BW; Colvin RB
    Prog Clin Biol Res; 1984; 146():81-6. PubMed ID: 6201925
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ.
    Sobel RA; Blanchette BW; Bhan AK; Colvin RB
    J Immunol; 1984 May; 132(5):2393-401. PubMed ID: 6371137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic-relapsing experimental autoimmune encephalomyelitis. Myelin basic protein induces suppression of blastogenesis during remissions but not during exacerbations.
    Lyman WD; Brosnan CF; Raine CS
    J Neuroimmunol; 1985; 7(5-6):345-53. PubMed ID: 2579093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
    Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared.
    Ford AL; Goodsall AL; Hickey WF; Sedgwick JD
    J Immunol; 1995 May; 154(9):4309-21. PubMed ID: 7722289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral vascular endothelial cells are effective targets for in vitro lysis by encephalitogenic T lymphocytes.
    McCarron RM; Racke M; Spatz M; McFarlin DE
    J Immunol; 1991 Jul; 147(2):503-8. PubMed ID: 1712809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic relapsing experimental allergic encephalomyelitis. Cytotoxicity effected by a class II restricted T cell line specific for an encephalitogenic epitope.
    Fallis RJ; McFarlin DE
    J Immunol; 1989 Oct; 143(7):2160-5. PubMed ID: 2476499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of guinea pig class II major histocompatibility complex antigens on vascular endothelial cells in vitro and in experimental allergic encephalomyelitis.
    Wilcox CE; Baker D; Butter C; Willoughby DA; Turk JL
    Cell Immunol; 1989 Apr; 120(1):82-91. PubMed ID: 2649258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.
    Racke MK; Burnett D; Pak SH; Albert PS; Cannella B; Raine CS; McFarlin DE; Scott DE
    J Immunol; 1995 Jan; 154(1):450-8. PubMed ID: 7527821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of experimental allergic encephalomyelitis in guinea/pigs by liposome-associated human myelin basic protein.
    Strejan GH; Percy DH; St Louis J; Surlan D; Paty DW
    J Immunol; 1981 Nov; 127(5):2064-9. PubMed ID: 6170686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells.
    Soos JM; Morrow J; Ashley TA; Szente BE; Bikoff EK; Zamvil SS
    J Immunol; 1998 Dec; 161(11):5959-66. PubMed ID: 9834077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major role of antigen-presenting cells in the response of rat encephalitogenic T cells to myelin basic proteins.
    Sun D; Le J; Yang S; Malotkey M; Coleclough C
    J Immunol; 1993 Jul; 151(1):111-8. PubMed ID: 7686928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody.
    Mannie MD; Morrison-Plummer J; McConnell TJ
    J Immunol; 1993 Dec; 151(12):7293-306. PubMed ID: 7505025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.
    Weinberg AD; Wegmann KW; Funatake C; Whitham RH
    J Immunol; 1999 Feb; 162(3):1818-26. PubMed ID: 9973447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles.
    Mustafa M; Vingsbo C; Olsson T; Issazadeh S; Ljungdahl A; Holmdahl R
    J Immunol; 1994 Oct; 153(7):3337-44. PubMed ID: 7522259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein.
    Fritz RB; Chou CH; McFarlin DE
    J Immunol; 1983 Mar; 130(3):1024-6. PubMed ID: 6185565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and humoral immune response to MBP during the course of chronic relapsing EAE.
    Schwerer B; Schuller-Levis GB; Mehta PD; Madrid RE; Wisniewski HM
    Prog Clin Biol Res; 1984; 146():187-92. PubMed ID: 6201889
    [No Abstract]   [Full Text] [Related]  

  • 40. EAE TCR motifs and antigen recognition in myelin basic protein-induced anterior uveitis in Lewis rats.
    Buenafe AC; Offner H; Machnicki M; Elerding H; Adlard K; Jacobs R; Vandenbark AA; Adamus G
    J Immunol; 1998 Aug; 161(4):2052-9. PubMed ID: 9712079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.